MXPA02011545A - Virus del sindrome respiratorio y reproductor porcino (peesv), vacuna recombinante para el virus de la viruela. - Google Patents
Virus del sindrome respiratorio y reproductor porcino (peesv), vacuna recombinante para el virus de la viruela.Info
- Publication number
- MXPA02011545A MXPA02011545A MXPA02011545A MXPA02011545A MXPA02011545A MX PA02011545 A MXPA02011545 A MX PA02011545A MX PA02011545 A MXPA02011545 A MX PA02011545A MX PA02011545 A MXPA02011545 A MX PA02011545A MX PA02011545 A MXPA02011545 A MX PA02011545A
- Authority
- MX
- Mexico
- Prior art keywords
- respiratory syndrome
- porcine reproductive
- syndrome virus
- prrsv
- vaccine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24041—Use of virus, viral particle or viral elements as a vector
- C12N2710/24043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/10011—Arteriviridae
- C12N2770/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/10011—Arteriviridae
- C12N2770/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Communicable Diseases (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
Lo que se describe es un vector recombinante, tal como un virus, por ejemplo, un virus de la viruela, tal como el virus de la viruela de las aves, que contiene un ADN externo del virus del sindrome respiratorio y reproductor porcino. Lo que también se describe son composiciones inmunologicas que contienen el virus de viruela recombinante, para inducir una respuesta inmunologica en un animal hospedador, al cual se le administra la composicion inmunologica. También se describen métodos para el tratamiento o prevencion de enfermedades causadas por el virus del sindrome respiratorio y reproductor porcino, al administrar las composiciones inmunologicas de la invencion a un animal que necesite del tratamiento o que sea susceptible a la infeccion por el virus del sindrome respiratorio y reproductor porcino.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20665500P | 2000-05-24 | 2000-05-24 | |
PCT/IB2001/000870 WO2001089559A2 (en) | 2000-05-24 | 2001-05-18 | Porcine reproductive and respiratory syndrome virus (prrsv) recombinant avipoxvirus vaccine |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA02011545A true MXPA02011545A (es) | 2003-06-06 |
Family
ID=22767352
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA02011545A MXPA02011545A (es) | 2000-05-24 | 2001-05-18 | Virus del sindrome respiratorio y reproductor porcino (peesv), vacuna recombinante para el virus de la viruela. |
Country Status (12)
Country | Link |
---|---|
US (1) | US20030003112A1 (es) |
EP (1) | EP1283718A2 (es) |
JP (1) | JP2003533989A (es) |
KR (1) | KR20030036194A (es) |
CN (1) | CN1443076A (es) |
AU (1) | AU2001256582A1 (es) |
BR (1) | BR0111366A (es) |
CA (1) | CA2409874A1 (es) |
MX (1) | MXPA02011545A (es) |
PL (1) | PL360096A1 (es) |
WO (1) | WO2001089559A2 (es) |
ZA (1) | ZA200210230B (es) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7445924B2 (en) | 2000-11-23 | 2008-11-04 | Bavarian Nordic A/S | Modified Vaccinia Ankara virus variant and cultivation method |
ES2256323T5 (es) | 2000-11-23 | 2016-11-21 | Bavarian Nordic A/S | Variante del virus Vaccinia Ankara Modificado |
US7628980B2 (en) | 2000-11-23 | 2009-12-08 | Bavarian Nordic A/S | Modified vaccinia virus ankara for the vaccination of neonates |
KR20030082960A (ko) * | 2001-03-09 | 2003-10-23 | 베링거잉겔하임베트메디카게엠베하 | Prrs 바이러스의 약독화된 생균 균주 |
US7279166B2 (en) | 2001-12-12 | 2007-10-09 | Virginia Tech Intellectual Properties, Inc. | Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof |
US7276353B2 (en) * | 2001-12-12 | 2007-10-02 | Virginia Tech Intellectual Properties, Inc. | Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof |
US7906311B2 (en) | 2002-03-20 | 2011-03-15 | Merial Limited | Cotton rat lung cells for virus culture |
AU2003239805B2 (en) | 2002-04-19 | 2009-09-10 | Bavarian Nordic A/S | Modified vaccinia virus ankara for the vaccination of neonates |
EP1434858B2 (en) | 2002-09-05 | 2018-12-19 | Bavarian Nordic A/S | Method for the amplification of a poxvirus under serum free conditions |
DK1594970T3 (da) * | 2003-02-18 | 2008-11-17 | Helmholtz Zentrum Muenchen | Fremgangsmåde til generering af rekombinant MVA |
JP2005075752A (ja) * | 2003-08-29 | 2005-03-24 | Nippon Inst For Biological Science | 豚繁殖・呼吸障害症候群用ワクチン製剤 |
US7788663B2 (en) * | 2004-06-08 | 2010-08-31 | Covia Labs, Inc. | Method and system for device recruitment interoperability and assembling unified interoperating device constellation |
EP1773387B1 (en) * | 2004-06-25 | 2013-06-12 | Merial Ltd. | Avipox recombinants expressing foot and mouth disease virus genes |
US8834891B2 (en) | 2005-03-14 | 2014-09-16 | Boehringer Ingelheim Vetmedica, Inc. | Immunogenic compositions comprising Lawsonia intracellularis |
US8398994B2 (en) * | 2005-07-15 | 2013-03-19 | Boehringer Ingelheim Vetmedica, Inc. | Lawsonia vaccine and methods of use thereof |
EP1792996A1 (en) * | 2005-12-01 | 2007-06-06 | Consejo Superior de Investigaciones Cientificas | Nucleic acid sequences encoding vaccines against Porcine reproductive and respiratory syndrome virus (PRRSV) |
US8470336B2 (en) | 2006-05-25 | 2013-06-25 | Boehringer Ingelheim Vetmedica, Inc. | Vaccination of young animals against Lawsonia intracellularis infections |
WO2009029130A2 (en) * | 2007-05-30 | 2009-03-05 | Wyeth | Raccoon poxvirus expressing genes of porcine virus |
CL2008001806A1 (es) * | 2007-06-20 | 2008-09-05 | Wyeth Corp | Composicion de vacuna en emulsion agua en aceite que comprende un antigeno y un adyuvante en la fase acuosa; y metodo de elaboracion. |
WO2009037262A2 (en) | 2007-09-17 | 2009-03-26 | Boehringer Ingelheim Vetmedica, Inc. | Method of preventing early lawsonia intracellularis infections |
KR101420850B1 (ko) * | 2011-05-30 | 2014-08-13 | 건국대학교 산학협력단 | 돼지 생식기 호흡기 증후군 바이러스 유사입자 및 이를 이용한 백신 |
EP2714077B1 (en) * | 2011-06-01 | 2018-02-28 | Merial, Inc. | Needle-free administration of prrsv vaccines |
JPWO2016021276A1 (ja) * | 2014-08-08 | 2017-05-25 | 出光興産株式会社 | 豚繁殖・呼吸障害症候群防除剤 |
DE102015111756A1 (de) | 2015-07-20 | 2017-01-26 | Eberhard Karls Universität Tübingen Medizinische Fakultät | Rekombinanter Orf-Virus-Vektor |
CN107236824A (zh) * | 2017-06-29 | 2017-10-10 | 新希望六和股份有限公司 | 一种用于猪繁殖与呼吸综合征病毒特异性检测的荧光定量rt‑pcr试剂盒及应用 |
US20230241074A1 (en) * | 2020-05-29 | 2023-08-03 | University Of Connecticut | Inhibitors of porcine reproductive and respiratory syndrome virus |
CN116333060B (zh) * | 2023-05-15 | 2023-07-21 | 广州悦洋生物技术有限公司 | 猪繁殖与呼吸综合征病毒gp5蛋白及其制备方法和用途、基因、试剂盒和检测方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69233158T2 (de) * | 1991-03-07 | 2004-05-13 | Connaught Technology Corp., Greenville | Gentechnologisch hergestellter stamm für impfstoffe |
GB2289279B (en) * | 1994-05-13 | 1998-09-16 | Iberica Cyanamid | Diagnostic kits and vaccines containing recombinant PRRSV proteins |
AU729518B2 (en) * | 1995-06-07 | 2001-02-01 | Syntro Corporation | Recombinant fowlpox viruses and uses thereof |
FR2775601B1 (fr) * | 1998-03-03 | 2001-09-21 | Merial Sas | Vaccins vivants recombines et adjuves |
-
2001
- 2001-05-18 BR BR0111366-6A patent/BR0111366A/pt not_active Application Discontinuation
- 2001-05-18 CA CA002409874A patent/CA2409874A1/en not_active Abandoned
- 2001-05-18 AU AU2001256582A patent/AU2001256582A1/en not_active Abandoned
- 2001-05-18 CN CN01813156A patent/CN1443076A/zh active Pending
- 2001-05-18 WO PCT/IB2001/000870 patent/WO2001089559A2/en not_active Application Discontinuation
- 2001-05-18 EP EP01929903A patent/EP1283718A2/en not_active Withdrawn
- 2001-05-18 KR KR1020027015977A patent/KR20030036194A/ko not_active Application Discontinuation
- 2001-05-18 PL PL36009601A patent/PL360096A1/xx not_active Application Discontinuation
- 2001-05-18 JP JP2001585802A patent/JP2003533989A/ja not_active Withdrawn
- 2001-05-18 MX MXPA02011545A patent/MXPA02011545A/es unknown
- 2001-05-21 US US09/862,393 patent/US20030003112A1/en not_active Abandoned
-
2002
- 2002-12-18 ZA ZA200210230A patent/ZA200210230B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
WO2001089559A3 (en) | 2002-04-11 |
CN1443076A (zh) | 2003-09-17 |
PL360096A1 (en) | 2004-09-06 |
ZA200210230B (en) | 2003-10-27 |
BR0111366A (pt) | 2003-05-20 |
KR20030036194A (ko) | 2003-05-09 |
CA2409874A1 (en) | 2001-11-29 |
JP2003533989A (ja) | 2003-11-18 |
EP1283718A2 (en) | 2003-02-19 |
AU2001256582A1 (en) | 2001-12-03 |
WO2001089559A2 (en) | 2001-11-29 |
US20030003112A1 (en) | 2003-01-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA02011545A (es) | Virus del sindrome respiratorio y reproductor porcino (peesv), vacuna recombinante para el virus de la viruela. | |
PL352201A1 (en) | Porcine circovirus vaccine in recombinant poxvirus | |
WO2001016330A3 (en) | Prevention of affections associated with porcine circovirus-2 | |
ATE430200T1 (de) | Impstoff gegen den für atemwegs- und reproduktionserkrankungen beim schwein verantwortlichen virus | |
EE200300173A (et) | Vaktsiiniaviirus, selle valmistamine ja kasutamine, seda sisaldav farmatseutiline kompositsioon ja vaktsiin ning meetod immuunreaktsiooni mõjutamiseks | |
MA27699A1 (fr) | Vaccin contre vhc | |
GR3035458T3 (en) | Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immunostimulatory molecule | |
DE69536039D1 (de) | Wirtszelle enthaltend ein rekombinantes Virus, welches ein Antigen exprimiert und ein rekombinantes Virus, welches ein immunstimulatorisches Molekül exprimiert | |
DE69936977D1 (de) | Durch polynukleinsäuren vom reproduktiven und respiratorischen syndromvirus des schweines kodierte proteine | |
DK1090033T3 (da) | Partikler af HCV-kappeproteiner: Anvendelse til vaccination | |
TW200740454A (en) | Methods of vaccine administration, new feline caliciviruses, and treatments for immunizing animals against feline paraovirus and feline herpes virus | |
ID24174A (id) | Vector dari porcine adenovirus | |
BR0312474A (pt) | Partìcula viral adjuvante | |
MXPA06013388A (es) | Vector lentiviral recombinante para la expresion de una proteina flaviviridae y sus aplicaciones como vacuna. | |
ECSP024257A (es) | Proteinas antigenas del virus de la enfermedad de la mancha blanca en el camaron y usos de las mismas | |
BR112022004027A2 (pt) | Métodos para tratar doenças neovasculares oculares usando variantes de aav2 que codificam aflibercepte | |
RU2015113826A (ru) | Выделение вируса, родственного парвовирусу-2 собак, от енота | |
NO20060675L (no) | Forbedrede, rekombinante, humane interferon-beta-lb-polypeptider | |
WO1999053950A3 (en) | Live vaccines and methods of treatment therewith | |
EA200200743A1 (ru) | Рекомбинантное ослабление вируса репродуктивного и респираторного синдрома свиней (prrsv) | |
NZ512341A (en) | Polynucleotides between 15 and 100 base pairs in length coding for parapoxvirus ovis (PPVO)/vaccinia virus recombinant (VVOV) viral genome fragments | |
MX2022015489A (es) | Vacuna de virus vaccinia modificado de ankara (mva) recombinante contra la enfermedad del coronavirus. | |
BR0112486A (pt) | Poliproteìna, molécula de ácido nucleico, plasmìdeo, vacina recombinante ou vacina atenuada, composição farmacêutica, e, método para imunizar um indivìduo contra hiv | |
BR0108442A (pt) | Mutantes-ehv gm-negativos | |
TR200202169T1 (tr) | Tanı ve tedavide kullanım için pürifiye hepatit C virüsü zarf proteinleri. |